TUESDAY, Nov. 30, 2021 (HealthDay News) — Americans who are vaccinated and boosted against COVID-19 should have enough antibody protection to prevent severe illness if they become infected with the new Omicron variant, White House COVID response officials said Tuesday. Omicron has caused concern among medical experts due to aContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — The often debilitating condition known as chronic fatigue syndrome appears to be common among COVID-19 long-haulers. That’s the key takeaway from a fresh look at patients who continue to struggle with severe fatigue, poor sleep, brain fog, muscle aches and pains long afterContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend emergency use of Merck’s new antiviral pill to help prevent severe COVID-19 in high-risk patients. By a 13-10 count, the panelists recommended molnupiravir for use by older COVID-19 patientsContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Several Old Spice and Secret aerosol spray antiperspirants and hygiene products have been voluntarily recalled in the United States due to the presence of the cancer-causing chemical benzene, Proctor & Gamble says. Benzene exposure can occur by inhalation, orally and through the skin.Continue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Coffee lovers know a steaming cup of java can quickly deliver energy and mental clarity every morning, but new research suggests it may also guard against Alzheimer’s disease in the long run. “Worldwide, a high proportion of adults drink coffee every day, makingContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Older blood thinners, especially when taken in combination with daily low-dose aspirin, are associated with a higher risk of brain bleeds and death after hospital discharge in patients treated for head injury, new research shows. The risk fell when patients were taking oneContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant. The company noted that prior analyses suggest that its monoclonal antibody cocktail, and similar drugs, could lose effectiveness againstContinue Reading